McKesson Corporation (MCK)vsSynergy CHC Corp. Common Stock (SNYR)
MCK
McKesson Corporation
$879.75
-0.25%
HEALTHCARE · Cap: $108.85B
SNYR
Synergy CHC Corp. Common Stock
$1.17
+3.54%
HEALTHCARE · Cap: $13.16M
Smart Verdict
WallStSmart Research — data-driven comparison
McKesson Corporation generates 1150507% more annual revenue ($397.96B vs $34.59M). SNYR leads profitability with a 7.5% profit margin vs 1.1%. SNYR trades at a lower P/E of 4.2x. MCK earns a higher WallStSmart Score of 57/100 (C).
MCK
Buy57
out of 100
Grade: C
SNYR
Hold45
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+41.2%
Fair Value
$1622.09
Current Price
$879.75
$742.34 discount
Margin of Safety
+13.2%
Fair Value
$1.90
Current Price
$1.17
$0.73 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Earnings expanding 38.0% YoY
Generating 1.1B in free cash flow
Attractively priced relative to earnings
Conservative balance sheet, low leverage
Areas to Watch
Moderate valuation
ROE of 0.0% — below average capital efficiency
1.1% margin — thin
Operating margin of 1.6%
Smaller company, higher risk/reward
7.5% margin — thin
ROE of -3.6% — below average capital efficiency
Earnings declined 90.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : MCK
The strongest argument for MCK centers on Debt/Equity, Altman Z-Score, Market Cap. Revenue growth of 11.4% demonstrates continued momentum. PEG of 1.07 suggests the stock is reasonably priced for its growth.
Bull Case : SNYR
The strongest argument for SNYR centers on P/E Ratio, Debt/Equity. Revenue growth of 12.4% demonstrates continued momentum.
Bear Case : MCK
The primary concerns for MCK are P/E Ratio, Return on Equity, Profit Margin. Thin 1.1% margins leave little buffer for downturns.
Bear Case : SNYR
The primary concerns for SNYR are Market Cap, Profit Margin, Return on Equity.
Key Dynamics to Monitor
SNYR carries more volatility with a beta of 1.27 — expect wider price swings.
SNYR is growing revenue faster at 12.4% — sustainability is the question.
MCK generates stronger free cash flow (1.1B), providing more financial flexibility.
Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MCK scores higher overall (57/100 vs 45/100) and 11.4% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
McKesson Corporation
HEALTHCARE · MEDICAL DISTRIBUTION · USA
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.
Visit Website →Synergy CHC Corp. Common Stock
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Synergy CHC Corp. The company is headquartered in Westbrook, Maine.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?